-+ 0.00%
-+ 0.00%
-+ 0.00%

LeonaBio spotlights lasofoxifene at DAVA Oncology breast cancer summit

PUBT·08/12/2026 11:05:00
Listen to the news
LeonaBio spotlights lasofoxifene at DAVA Oncology breast cancer summit
  • LeonaBio will present lasofoxifene data at Dava Oncology’s 4th Summit on Breast Cancer in Kona, Hawaii, Aug. 18-22, 2026.
  • Jessica Tao will outline the Phase 3 ELAINE-3 trial of lasofoxifene with abemaciclib on Aug. 19, 2026.
  • David Portman will lead an industry lunch presentation on lasofoxifene development on Aug. 20, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LeonaBio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120700PRIMZONEFULLFEED9808281) on August 12, 2026, and is solely responsible for the information contained therein.